← Signal Board

United Therapeutics company information

유나이티드 테라퓨틱스NASDAQ:UTHR · Nasdaq · Healthcare
$541.70-5.19%
2026-10-02 close

United Therapeutics's company information is shown as of 2026-10-02. It is a security listed on Nasdaq, ticker UTHR. There are 12 published related companies.

About this company

United Therapeutics last closed at $541.70 (-5.19%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq.

1 guru reporting 13F holdings — Bridgewater (founded by Ray Dalio)

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F is quarterly and may be filed up to 45 days later.

Curated gurus reporting this holding

A curated subset of well-known investors — not the full institutional ownership.

Suppliers, competitors and related stocks

  • MedtronicCompetitor

    이식형/호흡기 치료 시장에서 경쟁

  • BayerCompetitor

    폐동맥고혈압(PAH) 치료제 경쟁

  • Johnson & JohnsonCompetitor

    PAH 및 희귀질환 치료제 경쟁

  • PfizerCompetitor

    호흡기·희귀질환 치료제 경쟁 가능성이 큼

  • MerckCompetitor

    PAH/폐질환 치료 및 관련 파이프라인 경쟁

  • LiquidiaCompetitor

    흡입형 폐동맥고혈압 치료제 개발 경쟁

  • Lung Biotechnology PBCRelated theme

    이종이식·장기재생이라는 핵심 사업 테마와 직접 연관

  • United Therapeutics Research & DevelopmentRelated theme

    희귀질환·PAH 파이프라인 중심 사업 테마

  • OrganOxRelated theme

    장기 보존/이식 생태계와 관련된 투자 테마

  • VericelRelated theme

    재생의학·세포치료라는 유사 헬스케어 테마

  • AstraZenecaCompetitor

    호흡기 질환 및 폐 관련 치료제 분야의 글로벌 경쟁사

  • Gilead SciencesCompetitor

    희귀질환·호흡기 질환 치료제 경쟁사

Major stocks in the same sector

2026-10-04 dataset

📦 ETFs holding this stock

by weight · top-10 constituents basis

Passive money holding this stock ≈ $377M(lower bound — top-10 basis, not a forecast)

Factual holdings info from daily disclosures — not a recommendation.

Look up another stock →

United Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q